MorphoSys, J&J deal

MOR and JNJ's Centocor Inc. subsidiary (Malvern, Penn.) added a new target to their December 2000 antibody deal (see BioCentury, Jan. 8, 2001). MOR will now use its HuCAL GOLD technology to generate a...